Renalytix AI plc

Company Profile

Company website
Medical Equipment and Services (Medical Equipment)
A developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. The Company uses AI to analyse different sources of information including blood-based biomarkers, genetics and large electronic health record data bases to improve diagnosis and clinical management of kidney disease. The Company is a spin-out of AIM-listed EKF Diagnostics Holdings plc and it's lead product KidneyIntelX™, which is being developed in close collaboration with Mount Sinai and other large US academic medical centres, is due to launch in 2019.

Investor Access Events

09 Mar
Event information
Investor presentation
Brand Exchange, 3 Birchin Lane, London EC3V 9BW
Monday, 9th March 2020, 5.15pm for a 5.30pm start